[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Jacobs institute\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":62},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100577035","evaluation-of-flow-diverter-technology-device-for-intracranial-aneurysm-shield-100577035",false,"NCT06793059","Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)","SHIELD","Inclusion Criteria:\n\n* Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.\n\nExclusion Criteria:\n\nExclusion Criteria:\n\n* Cannot provide consent or legally authorized representative not available to provide consent Criteria:","ALL","22 Years",{"count":19,"type":20},10,"ESTIMATED","INTERVENTIONAL",[23],"NA","The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms",[26],"Aneurysm","RECRUITING","2026-03-06",{"date":30,"type":31},"2026-03-10","ACTUAL",{"date":33,"type":31},"2025-01-01",{"date":35,"type":20},"2027-01-01",{"name":37,"class":38},"Jacobs institute","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":16,"minAge":47,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":21,"phases":50,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":39},"100603762","the-symani-restore-study-100603762","NCT07140731","The Symani Restore Study","An Early Feasibility Study for the Symani Surgical System","Inclusion Criteria:\n\n1. Patients aged \\>18.\n2. Moyamoya disease with minor to moderate symptoms requiring neurosurgical treatment.\n3. Patients agree to have the surgery and the anesthesia.\n4. Patients who voluntarily decide to participate in this study with the surgery performed with the aid of Symani and agree to sign the Informed Consent Form.\n\n   \\-\n\nExclusion Criteria:\n\n1. Patients who have bleeding or coagulation disorders in the past or present.\n2. Any criteria that preclude prolonged anesthesia.\n3. Hemodynamically unstable neurological exam.\n4. Pressure dependent neurologic status.","18 Years",{"count":49,"type":20},15,[23],"A research study for a neurosurgical procedure in adult patients with Moyamoya disease",[53],"Moyamoya Disease","2025-10-14",{"date":56,"type":31},"2025-10-16",{"date":58,"type":31},"2025-09-20",{"date":60,"type":20},"2027-09-01",{"name":37,"class":38},""]